Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques

Published:2018-12-21 Issue:5 Volume:34 Page:708-716
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Johnston Tom H.¹²,Geva Michal³,Steiner Lilach⁴,Orbach Aric⁴,Papapetropoulos Spyros⁴,Savola Juha‐Matti⁵,Reynolds Ian J.⁶,Ravenscroft Paula¹²,Hill Michael¹²,Fox Susan H.⁷,Brotchie Jonathan M.¹²,Laufer Ralph⁸,Hayden Michael R.³

Affiliation:

1. Atuka Inc Toronto Ontario Canada

2. Krembil Research InstituteToronto Western Hospital, University Health Network Toronto Ontario Canada

3. Prilenia Therapeutics Development Ltd. (formerly 4) Herzliya Israel

4. Global Research and DevelopmentTeva Pharmaceutical Industries, Ltd. Netanya Israel

5. Teva Pharmaceuticals International, GmbH Basel Switzerland

6. Rewind TherapeuticsLeuven (formerly 4) Belgium

7. Movement Disorders Clinic, Toronto Western HospitalUniversity Health Network Toronto Ontario Canada

8. Lysogene S.A. (formerly 4) Neuilly sur Seine France

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27565

Reference29 articles.

1. Levodopa-Induced-Dyskinesias Clinical Features, Incidence, Risk Factors, Management and Impact on Quality of Life

2. Levodopa-dyskinesia incidence by age of Parkinson's disease onset

3. Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study

4. Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease

5. Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WLB-87848, a Selective σ₁ Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity;Journal of Medicinal Chemistry;2024-05-16

2. Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies;Current Neuropharmacology;2023-05

3. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders;CNS Drugs;2023-05

4. Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose;Neurology and Therapy;2023-02-22

5. Pathophysiology and Management Approaches for Parkinson’s Disease;Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3